Drug Profile
Human prothrombin complex - Shanxi Kangbao Biological Product
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Shanxi Kangbao Biological Product
- Class Blood coagulation factors
- Mechanism of Action Factor IX stimulants; Factor VII stimulants; Factor X stimulants; Prothrombin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemorrhage; Surgical blood loss
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for clinical-Phase-Unknown development in Haemorrhage in China (IV)
- 28 Feb 2019 No recent reports of development identified for clinical-Phase-Unknown development in Surgical-blood-loss in China (IV)
- 14 Jan 2016 Clinical trials in Haemorrhage in China (IV) prior to January 2016 (Shanxi Kangbao Biological Product pipeline, January 2016)